Ongoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAF(V600E) mutated, microsatellite-stable colon cancer: A case report and literature review

Metastatic BRAF(V600E) mutated colorectal cancer is associated with poor overall survival and modest effectiveness to standard therapies. Furthermore, survival is influenced by the microsatellite status. Patients with microsatellite-stable and BRAF(V600E) mutated colorectal cancer have the worst pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Piringer, Gudrun, Decker, Jörn, Trommet, Vera, Kühr, Thomas, Heibl, Sonja, Dörfler, Konrad, Thaler, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196488/
https://www.ncbi.nlm.nih.gov/pubmed/37213293
http://dx.doi.org/10.3389/fonc.2023.1166545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196488/
https://www.ncbi.nlm.nih.gov/pubmed/37213293
http://dx.doi.org/10.3389/fonc.2023.1166545

Ejemplares similares